A phase 1 study of a chimeric monoclonal antibody against interleukin-6, siltuximab, combined with docetaxel in patients with metastatic castration-resistant prostate cancer
Hudes, Gary, Tagawa, Scott T., Whang, Young E., Qi, Ming, Qin, Xiang, Puchalski, Thomas A., Reddy, Manjula, Cornfeld, Mark, Eisenberger, MarioVolume:
31
Langue:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-012-9857-z
Date:
June, 2013
Fichier:
PDF, 208 KB
english, 2013